Telecobalt therapy for malignant lung tumours

The authors present the results of telecobalt therapy in 194 patients with malignant lung tumours treated between 1967 and 1971. The 3- and 5-year survivals were 9.7 and 5.4% respectively, with an average survival of 15 months. The results obtained depend on the microscopy, the clinical staging and on the irradiation techniques possible; several prognostic groups may be distinguished.